Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation - Wikidata - awgldk - TriplyDB

Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation

Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation

http://www.wikidata.org/entity/Q28482381

about

Novel GPCR paradigms at the μ-opioid receptor Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines.Ligand bias at the μ-opioid receptor.Chemical methods for peptide and protein production.Efficacy and ligand bias at the μ-opioid receptor.Tryptophan-Containing Non-Cationizable Opioid Peptides - a new chemotype with unusual structure and in vivo activity.The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.

P2860

Q26864286-64112292-ED88-4795-BA73-B9F815846C00 Q26991917-36E85677-16B4-412A-860D-C7C9C36DD8F8 Q33875227-66ED532E-7089-41CE-BCCE-56ADFD177CC6 Q35615157-FB6CFF8A-BD77-4E15-AD05-51F278C69A80 Q38077231-BEC71750-A19D-4E03-8EC2-530C28DA8101 Q38098836-A0E243F0-DA78-46A5-B9AF-E284F633A636 Q38104365-B6924864-6B8B-4868-B14B-2E74906738AD Q44350759-1D4E56CB-0E89-431A-A693-97830D4798FF Q54977077-F0FDCC72-26C0-4396-823F-CC0A032D74E5

P2860

Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation

http://www.wikidata.org/entity/Q28482381

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Lipo-endomorphin-1 derivatives ...... without producing constipation

@ast

Lipo-endomorphin-1 derivatives ...... without producing constipation

@en

Lipo-endomorphin-1 derivatives ...... without producing constipation

@nl

type

label

Lipo-endomorphin-1 derivatives ...... without producing constipation

@ast

Lipo-endomorphin-1 derivatives ...... without producing constipation

@en

Lipo-endomorphin-1 derivatives ...... without producing constipation

@nl

prefLabel

Lipo-endomorphin-1 derivatives ...... without producing constipation

@ast

Lipo-endomorphin-1 derivatives ...... without producing constipation

@en

Lipo-endomorphin-1 derivatives ...... without producing constipation

@nl

P1433

Q28482381-9CF85F81-6FA9-46A1-B5F1-0E888DC6C51E

P1476

Q28482381-4D0BF49A-DA33-4C54-ADAA-B9B98FDC2B23

P2093

Q28482381-957D3412-B7A8-41EC-9E94-358BCAE7B570

Q28482381-EBCD8D89-4A1B-40CB-9A0D-254284F1C094

P2860

Q28482381-01E14FA5-E7AF-48CA-87F8-4C3A081AA1BC

Q28482381-0729C18F-AC75-476D-8C20-F62AAAA1B216

Q28482381-0E0023AB-C786-4DE7-88E5-F8837595CAC4

Q28482381-10E72333-553F-4C01-A024-C75DD596232A

Q28482381-11C940D1-FCC9-42D3-BC54-413BF34DD202

Q28482381-14ED36DC-DEFC-4B4E-AAB9-C132D2A8C0FC

Q28482381-152237D3-0541-4C73-AE26-D043FA779AFD

Q28482381-2C3ACC73-B6F2-47F0-8AC7-D4DBC4A89829

Q28482381-3AFAFE09-9FC5-4C6F-9819-E6802514D29D

Q28482381-3EBFEC28-3334-4E30-809B-4F2923437114

P304

Q28482381-7ABD9DF9-196E-466F-8361-9439A5F2B3E2

P31

Q28482381-D7C34AF8-755B-4B42-997D-CF9C116D612B

P356

Q28482381-8796CDCC-B7C9-4FFA-8292-D6E717EAEE2C

P407

Q28482381-02ED2C8F-5FE4-4A78-BAE2-1E9E2557E4EF

P433

Q28482381-5ACCC97A-A958-4022-A789-08C58F5180D4

P478

Q28482381-65F8170E-E44B-428E-8951-D908AA6515E3

P50

Q28482381-04723447-2FB6-4952-AAB2-82BBD578AA7F

Q28482381-13838FBE-E2F7-4A5B-A8DE-601646439B1F

Q28482381-BA0C4E37-7F20-44A3-80D1-D0973DCF0E2A

Q28482381-F4B2D971-6D1E-4A77-86AF-2DEB8778116F

P577

Q28482381-6A59A2A2-1DB7-46AC-9E92-82659585CFA4

P5875

Q28482381-E9E564D5-F8A0-4B6B-BA5B-A4BC1D68A030

P698

Q28482381-36B424FA-83B2-4EB5-ACDF-E790ADE22414

P921

Q28482381-12B12DC5-D60A-41D9-94B4-61D85FFDF977

P932

Q28482381-7B2BCED8-DA2B-4EB6-BD76-7577E1F48205

P356

JOURNAL.PONE.0041909

P1433

P1476

Lipo-endomorphin-1 derivatives ...... without producing constipation

@en

P2093

Bruce D Wyse

http://www.w3.org/2001/XMLSchema#string

Friederike M Mansfeld

http://www.w3.org/2001/XMLSchema#string

P2860

Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain

The blood-nerve barrier: enzymes, transporters and receptors--a comparison with the blood-brain barrier.

Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.

Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists.

The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics.

A potent and selective endogenous agonist for the mu-opiate receptor.

Opioids in chronic pain.

Pharmacologic management of neuropathic pain: evidence-based recommendations.

Neuropathic pain: redefinition and a grading system for clinical and research purposes.

Analgesia produced by morphine when acting from the liquor space.

P304

e41909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0041909

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Joanne T Blanchfield

P577

2012-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230716303

http://www.w3.org/2001/XMLSchema#string

P698

22912681

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

P932

3422351

http://www.w3.org/2001/XMLSchema#string